L9LS in Women of Childbearing Potential in Mali

Safety and Efficacy of L9LS, a Human Monoclonal Antibody Against Plasmodium falciparum, in a Randomized, Double-Blind, Placebo-Controlled Trial of Women of Childbearing Potential (WOCBP) in Mali

NCT Number	NCT07060508
Lead Sponsor	National Institute of Allergy and Infectious Diseases (NIAID) Collaborators: National Institutes of Health (NIH), Malaria Research and Training Center, Bamako, Mali, University of the Sciences, Techniques and Technologies of Bamako, Faculté de Médecine Pharmacie d'Odontostomatologie (FMOS), University of Washington, Harvard School of Public Health (HSPH), Indiana University
Conditions	Malaria
Enrollment	279 participants
Start Date	2025-07-22
Primary Completion	2026-04-13 (estimated)
Study Completion	2026-04-13 (estimated)
Updated on ClinicalTrials.gov	2026-06-10